Pharmafile Logo

Striving to become more patient-centric?

August 25, 2020 |  

Explore more with OPEN Health

Patients are increasingly involved in their healthcare decisions. They have become empowered and informed data-driven advocates for their own health. We are currently at a tipping point in the industry as regulatory bodies and patient advocacy groups have come together to reinforce the importance of the role of patients in the drug development process.

Why now?

  • Patient engagement tools have evolved considerably
  • There is an increased role of patients in regulatory and health technology decision making
  • Healthcare players who are unable or unwilling to deepen collaborations in the industry may find it difficult, if not impossible, to participate in a future patient-driven healthcare system

But how does a patient-centric approach evolve from a one-off engagement tactic to a fully integrated, company-wide practice?

Join us and take an interactive tour through today’s modern approach to patient-centricity. We will show how patient-centricity can be integrated into all phases of development and commercialization and show examples of how to achieve patient buy-in and ensure the patient voice is represented in your study outcomes.

Start Your Journey

In this interactive journey, you will:

  • Learn about the value of a patient-centric approach
  • Explore areas to focus on at different phases of the product life cycle
  • See real-life case studies of how a patient-centric approach can be used in therapeutic areas such as oncology, rare disease and advanced therapies
  • Find out how to take your first step to a patient-centric approach
  • Meet our team of experts and what drives them

Pink divider

Pharmerit – an OPEN Health Company has been at the forefront of the evolution of patient-centricity. We have seen the positive impact of engaging patients throughout the product lifecycle. We believe it is important to include patient-centricity in every project we undertake, combining expertise with outcomes to see the impact of co-creation.

This content was provided by OPEN Health

Company Details

 Latest Content from  OPEN Health 

OPEN Health attend EB World Congress—building on momentum and strength in numbers for epidermolysis bullosa

Ben Speller shares his thoughts on the value of disease specific congresses

OPEN Health use PR to support clinical trial recruitment

International Clinical Trials Day finds clinical research in the spotlight like never before, with any news coming from the many studies into potential vaccines and treatments for SARS-CoV-2

OPEN Health | European Congress on Rare Diseases (ECRD) 2020 in 60 seconds

Gavin Jones, Director or Rare Disease, attends the congress to better understand the viewpoints of patient groups, health systems and payers

OPEN Health attend day 2 of the ECRD2020 congress

Gavin Jones is looking forward to sessions on innovation in advanced therapies and working towards equitable access.

OPEN Health continued support for My Name’5 Doddie

Charity fundraising for Motor Neuron Disease

OPEN Health’s latest partnership with Rare Revolution Magazine

Richard Jones introduces our Head of Health Psychology (Dr Sumira Riaz)

OPEN Health CSR Report 2019

Margot Hannah, Partner and Group Managing Director, and CSR lead at OPEN Health shares her thoughts on our latest report.

OPEN Health at ECRD 2020

Gavin Jones shares his thoughts on why congress is so important at this time and the key sessions he is looking forward to.

OPEN Health discuss Global Community in Rare Disease

Annie Rankin how we can work smarter with healthcare professionals

OPEN Health Patient & Brand Communications highly commended finalist

Shortlisted for Best Patient-Centric Approach for 2020 BOBI Awards.